Lonza enters a collaborative agreement with Auxly for capsule formulation

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/okskaz)
(Image: Getty/okskaz)

Related tags: Lonza, Capsules, formulation, Drug delivery, bioavailability, processing, equipment, Manufacturing, Cannabis

Lonza will supply Auxly with materials and proprietary manufacturing equipment for capsule filling and sealing through collaborative agreement.

Through this agreement, Auxly’s wholly-owned subsidiary Dosecann will receive a complete line of equipment needed for capsule filling and sealing, alongside with Lonza’s Capsugel LEMS machine – its proprietary liquid-filled Licaps capsules, and rights to the capsule filling and sealing LEMS technology.

Additionally, Dosecann and Lonza will work on new product formulation for cannabis capsule products as part of the agreement. 

Lonza’s Capsugel technology is currently used in health applications for bioavailability enhancement, taste and odor masking, combination products, and controlled and delayed release formulations.

Greg Boone, CEO of Dosecann, told us that the use of formulated capsules has the potential to gain a large share in the medical market, as people are familiar with dosage forms.

Boone added that Dosecann has begun formulation for capsules and has just completed its first batch of capsules utilizing the Capsugel equipment.

Through this agreement, Doescann will be commissioning the LEMS technology at its good manufacturing practice (GMP) compliant facility in Charlottesville, Canada. 

The facility will have a full manufacturing line with the capacity to fill and seal up to 200 million Capsugel Licaps per year.

Related news

Show more

Related products

show more

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Related suppliers

Follow us


View more